Simon Quick Advisors’s vTv Therapeutics VTVT Stock Holding History

Simon Quick Advisors’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-750	Closed	-$14.3K	–	382
2023 Q3	$14.3K	Hold	750	–	–	﹤0.01%	351
2023 Q2	$22.2K	Hold	750	–	–	﹤0.01%	284
2023 Q1	$24.2K	Hold	750	–	–	﹤0.01%	275
2022 Q4	$19.6K	Hold	750	–	–	﹤0.01%	244
2022 Q3	$29K	Hold	750	–	–	﹤0.01%	200
2022 Q2	$36K	Buy	+750	New	+$19.2K	﹤0.01%	176

Other funds holding VTVT

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Simon Quick Advisors's VTVT Position: Q4 2023 in Review

Simon Quick Advisors sold out of vTv Therapeutics (VTVT) in Q4 2023, closing a stake of 750 shares — an estimated $14.3K sold.

Simon Quick Advisors first reported a position in VTVT in Q2 2022 and held it in 6 quarters. The position peaked at $36K in Q2 2022. 14 funds tracked by Wall St. Rank hold VTVT as of Q4 2023.

Simon Quick Advisors reported no remaining vTv Therapeutics position as of Q4 2023 after selling out during the quarter.
Simon Quick Advisors sold 750 vTv Therapeutics shares in Q4 2023, an estimated $14.3K.
Simon Quick Advisors first reported a position in vTv Therapeutics in Q2 2022 and held it in 6 quarters.
Simon Quick Advisors's vTv Therapeutics position peaked at $36K in Q2 2022.
14 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2023.

Based on Simon Quick Advisors's 13F filing for Q4 2023, filed 16 Jan 2024.